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ABSTRACT: In this work, we demonstrate a semibatch
so l i d - s t a t e de r a c emi z a t i on p roc e s s f o r N - (2 -
chlorobenzylidene)henylglycine amide (NCPA), a complex
chiral polymorphic system that involves three types of
crystalline racemates (racemic compound and conglomerate
forms I and II). In this process, gradually fed metastable
racemic compound crystals are converted in situ to crystals of
the preferred (seeded) enantiomer under grinding conditions
through a series of solvent-mediated transformations in a
racemizing solution. The phase diagram for this system shows
that while conglomerate form II is stable under the conditions examined (acetonitrile at 21 °C), form I crystals of a single
enantiomer (used as seeds) are unstable at (nearly) racemic compositions and convert to the racemic compound upon addition
of the racemization catalyst. Thus, care needs to be exercised in order to fully convert form I to form II before addition of the
racemization catalyst in order to prevent the undesired crystallization of the racemic compound. This can be achieved by adding
a small amount of water, which is found to enhance the nucleation and growth kinetics of the most stable conglomerate form II,
eventually leading to complete deracemization. Importantly, we show that this special deracemization process can be easily
monitored online by Raman spectroscopy, which gives access to the evolution of the solid-phase composition. For the studied
system, this information can in turn be used to directly estimate the solid-phase enantiomeric excess online throughout the
process, as long as conglomerate crystals of the counter enantiomer do not form.
1. INTRODUCTION
In the past decade, solid-state deracemization processes such as
Viedma ripening1 and temperature cycling-enhanced deracem-
ization2 have gained considerable attention as feasible means to
obtain enantiopure solid products.3−11 Most of these processes
are typically carried out in laboratory-scale batch mixed
crystallizer vessels, where a population of conglomerate crystals
close to the racemic composition is suspended in a (nearly)
saturated solution in which fast solution-phase racemization
occurs. Under these conditions, intense grinding ensured by the
presence of grinding media or programmed heating and cooling
cycles in the suspension drive the solid phase to a homochiral
end state (enantiomeric purity >99.9%) in an autocatalytic
fashion. While the exact mechanisms under which this occurs
have been debated,3−6 the method is generally very reliable,
requires little information prior to its application, and is in
theory very productive, as the amount of enantiopure solid
obtained in a single batch is not limited by the solubility of the
compound in the solvent. The feasibility of deracemization
processes has now been demonstrated for a plethora of chiral
compounds, such as amino acids7,8 and their derivatives,9−11
pharmaceutical intermediates,12,13 and organometallic com-
plexes,14 while their application in compounds with more than
one chiral center was also recently realized.15
Crucial prerequisites for any successful deracemization
process are facile solution-phase racemization and conglomerate
crystallization (each enantiomer forming individual crystals).12
However, the majority of chiral molecules, when they are
crystallized from racemic mixtures, form racemic compounds
(i.e., individual crystals that contain both enantiomers in equal
amounts). The racemic compound and conglomerate crystals
possess diﬀerent crystal structures and in the presence of fast
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solution racemization can be considered as polymorphs,16
allowing the possibility for interconversion between the two
forms through solvent-mediated crystal transformations.17 In
our previous works,18,19 we have shown independently that
combining such a transformation of a racemic compound to a
conglomerate with Viedma ripening, despite the presence of the
racemic compound, can still lead to enantiopurity. Using this
transformation, remarkably, the rate of deracemization was
substantially increased (by a factor of 10) in comparison to
“conventional” Viedma ripening.
Simulations of this special deracemization process20 revealed
that enantiopurity is attained through a combination of
preferential crystallization in the presence of a racemization
agent (also termed second-order asymmetric transformation,
SOAT17) and Viedma ripening. The dominant deracemization
mechanism depends heavily on the crystal transformation
kinetics21 and is determined by the extent of nucleation of the
counter enantiomer. If the latter does not occur, deracemization
proceeds purely by SOAT, leading to the fastest deracemization
possible, while in the case of counter enantiomer formation,
Viedma ripening is required to reach enantiomeric purity,
leading to a slower process.20 In the same study, it was shown
theoretically that, if the racemic compound is highly metastable
with respect to the conglomerate, the amount of racemic
compound added must be carefully managed in order to control
the supersaturation generated and prevent nucleation of the
counter enantiomer. Therefore, a continuous or semicontinuous
operating mode, where the racemic compound is gradually
added to the suspension containing seeds of the preferred
enantiomer, may be advantageous to enhance the process
productivity and would constitute an important step toward the
development of continuous deracemization processes. The
beneﬁts of in situ gradual feeding in Viedma ripening were also
demonstrated in a process where the compound to be
deracemized was generated in situ by a chemical reaction.13
Such a process was shown to achieve a higher deracemization
rate in comparison to conventional Viedma ripening (which
starts at a nearly racemic composition), since it avoids operation
at low enantiomeric excess regions where the deracemization
rate is slow.
Process analytical technologies (PATs) have become integral
in the operation of (semi)continuous crystallization processes,
as they enable real-time monitoring of critical process
parameters and can be used to develop feedback control
strategies and automation.22 However, for chiral resolution and
deracemization processes this has not yet been possible, as the
PATs currently available are chirally blind and cannot
diﬀerentiate between the enantiomer solutes and crystals. The
traditional analytical methods that yield the enantiomeric excess,
and thus the evolution of the process, rely onmanual sampling of
the solid phase and sample preparation followed by chiral HPLC
and/or polarimetry. On the other hand, online Raman
spectroscopy,23 although being chirally blind as well, may be
suitable for the in situ monitoring of the crystal transformation/
deracemization process, since Raman can detect the speciﬁc
lattice vibrations for diﬀerent crystal structures.24 Hence, Raman
is capable of distinguishing between enantiomers packed in
diﬀerent crystal structures (racemic compounds, conglomer-
ates).25 Although several authors have reported the ability of
monitoring the solid-phase fractions of diﬀerent polymorphs
during solvent-mediated transformations using online Raman
spectroscopy,26−31 to our knowledge there has been no previous
work reported using Raman to quantitatively determine the
compositions of racemic and conglomerate crystals of chiral
compounds undergoing a dissolution/crystallization process. In
addition, chemometric treatments can be applied to the Raman
spectra,32−34 allowing accurate monitoring of the solid-phase
composition when more than two solid phases are in-
volved.35−37
In this work, we present a semibatch deracemization process
for chiral N-(2-chlorobenzylidene)phenylglycine amide
(NCPA), which is based on the conversion of racemic crystals
fed to a racemizing suspension containing seed crystals of the
preferred enantiomer in the presence of grinding. Furthermore,
through estimation of the phase diagram, we determine regions
of stability for the three solid phases involved (two
conglomerates and a racemic compound) and we reveal the
crucial eﬀect of water content on the outcome of the crystal
transformations between the solid phases, which ultimately
aﬀects the deracemization process. Finally, we demonstrate for
the ﬁrst time the relevance and applicability of Raman
spectroscopy for the online monitoring of this special
deracemization process.
2. EXPERIMENTAL SECTION
2.1. Synthesis of Starting Materials. N-(2-Chlorobenzylidene)-
phenylglycine amide (NCPA) was used as a model compound in this
study, which according to George et al.38 crystallizes in three forms, two
of which are conglomerates and one is a racemic compound. Racemic
NCPA and enantiopure R-NCPA were synthesized after slight
modiﬁcations of a reported procedure.39 The details of the chemical
synthesis and isolation of NCPA as a racemic compound and
conglomerates I and II are reported in the Supporting Information.
2.2. Solubility Measurements. The solubility of the three solid
phases of NCPA was determined in various acetonitrile/water mixtures
in the presence and absence of the racemization catalyst DBU at the
experimental temperature of 21 °C. A known amount (∼0.1 g) of pure
NCPA of the desired phase (conglomerate I or II or the racemic
compound) was weighed in a 5 mL glass vial equipped with a magnetic
stirrer, and a known amount (∼1.6 g) of solvent was added. The vials
were placed inside a Crystalline apparatus (Technobis B.V.) and were
stirred at 1200 rpm for 48 h at 21 °C to ensure attainment of a solid−
liquid equilibrium, after which the solubility was determined gravi-
metrically. Each measurement was conducted at least twice, and the
relative deviation was less than 5%. The resulting solid phase was
subsequently analyzed via Raman spectroscopy to conﬁrm that crystal
transformation had not taken place.
2.3. Deracemization Experiments. Figure 1 (top) presents the
experimental setup used for all deracemization experiments by
conversion of the racemic compound to a conglomerate, which consists
of a jacketed 30 mL round-bottom ﬂask containing a total solution
volume of about 20 mL. All experiments were conducted at 21 °C, and
samples were stirred at 500 rpm using amagnetic stirring bar (length 2.5
cm, Ø 1 cm) in the presence of 10 g of glass beads (Ø 2 mm) to enable
particle breakage. The reactor was brought in external contact with a
Raman probe, as seen in Figure 1, to allow in situ measurements of the
Raman spectra in the suspension through the glass and the reactor
jacket. This conﬁguration proved advantageous in comparison to
positioning direct contact probes in the suspension that can be
damaged by the glass beads and are impractical on a small scale, but the
spectra recorded required processing to reduce the background
interference caused by the presence of the glass. Figure 1 (bottom)
shows the racemization reaction of NCPA enabled by catalytic amounts
of diazabicyclo[5.4.0]undec-7-ene (DBU).
2.3.1. Batch Experiments. For the batch deracemization experi-
ments, a known amount of R-NCPA (form I) was mixed with a known
amount of RS-NCPA (racemic compound) and placed in the reactor
together with the glass beads (10 g). Subsequently, 20 mL of
acetonitrile was placed in the reactor, stirring was initiated, and the
Raman measurements were started (with a delay of about 8 min) to
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monitor the time evolution of the solid-phase composition. After 17
min, 0.2 mL of DBU was added to initiate racemization. For some
experiments, small amounts of water (0.65−3.9 mL) were added
immediately after the addition of the acetonitrile.
2.3.2. Semibatch Experiments. For the semibatch deracemization
experiments, initially the same procedure was followed as for the batch
experiments. After startup, the racemic compound was fed periodically
to the reactor by opening the reactor and manually adding a known
amount of dry RS-NCPA (racemic compound). Together with the
racemic compound, small amounts of water were added as well.
2.3.3. Sampling. In all experiments, suspension samples were
periodically extracted using a pipet (0.2 mL) and the solid was ﬁltered
over preweighed paper ﬁlters, washed using 1 mL of diisopropyl ether,
and oven-dried overnight at 30 °Cunder vacuum. After a determination
of the solid mass, the solids were subjected to oﬄine Raman
spectroscopy to determine the weight fractions of the various phases
(XRAC, XI, and XII for the racemic compound and forms I and II,
respectively) and enantiomeric excess, E, determination via chiral
HPLC. After the end of each experiment, the solids in the reactor were
collected and dried to determine the solid yield, y, according to
y
m
m C m
r
t II s
=
− * (1)
where mr is the mass recovered at the end of the experiment, mt is the
total mass of the solids added, ms is the mass of the solvent mixture and
CII* is the solubility of conglomerate form II at 21 °C in the respective
solvent mixture.
2.4. Online Quantiﬁcation of Solid-Phase Fractions by
Raman Spectroscopy. Raman spectra were collected through the
reactor glass jacket via contactless in situ measurements (Figure 1 using
a process Raman analyzer (Kaiser RXN2, PhatProbe) spectrometer at
785 nm laser excitation. The spectra were captured with an exposure
time of 10 s and 6 accumulations over 2−3min. A laser spot diameter of
6 mm was used so that suﬃcient solid mass was sampled in each
acquisition to reliably detect the diﬀerent solid forms suspended in the
liquid. Oﬄine spectra were taken as well for ﬁltered solid samples from
the suspension using the same method in order to compare with the in
situ data. All raw spectra ﬁles were pretreated using MATLAB by ﬁrst
taking the second derivative of each spectrum with respect to
wavelength via the Savitzky−Golay algorithm using a second-order
polynomial, a seven-point smoothing window, and standard normal
variate (SNV) transformation, to reduce baseline shift eﬀects and to
increase peak resolution and deconvolution.40
For quantiﬁcation of the solid-phase fractions, a calibration model
was developed (see the Supporting Information for the details). For this
purpose, 30 ternary solid mixtures of the three forms of NCPA having
various known solid compositions were prepared and partial least-
squares (PLS) regression analysis was performed in MATLAB
(SIMPLS algorithm41) on the pretreated calibration spectra using
three latent variables (LVs). It was found that the ﬁrst three LVs are
suﬃcient to explain 99.53% of the total variance in the data and aﬀord a
minimum root-mean-square error of prediction (RMSEP). In order to
assess the predictive capabilities of the calibration model, an
independent validation set of four samples was prepared. Table S1 in
the Supporting Information shows the actual versus predicted values of
the mass fractions of the three solid phases giving RMSEP values of
1.93%, 1.58%, and 0.79% for the racemic compound and forms I and II,
respectively, which were considered suﬃcient in the present study.
Strictly speaking, this calibration approach is only valid for oﬄine
analysis of dried solid samples. It is known that, for accurate in situ
monitoring using Raman, it is best to prepare the calibration samples
under conditions as close to those of the experiments as possible23,33 (in
a stirred suspension at the right process temperature and suspension
density, with additional parameters such as particle size and shape), as
the Raman spectra can be infuenced by varying conditions, and peaks
due to the solvent would appear in the spectra. However, taking
accurate calibration spectra in suspensions is challenging when fast
solvent-mediated transformations occur and models accounting for the
eﬀects of suspension density and particle size/shape together with
solid-phase composition for more than two phases can be quite
complex. For this reason, we decided to assess the capability of
extending the present (oﬄine) calibration to online measurements.
This was done by applying the same data preprocessing and prediction
procedure for oﬄine and online measurements, which showed good
overall agreement (see the Supporting Information for a comparison of
the oﬄine and online data for all reported experiments). It is noted that,
in order for this to hold, care must be taken to exclude spectral regions
from the analysis that are inﬂuenced by the presence of additional
compounds such as the solvent, glass beads and wall, and racemization
catalyst.
2.5. HPLC Analysis for Determination of the Solid-Phase
Enantiomeric Excess. All dried solid samples were dissolved in
ethanol, and their enantiomeric excesses were determined by chiral
HPLC analysis using an Agilent 1290 UPLC apparatus. The
enantiomers of NCPA were separated in a Phenomenex Lux 3 μm i-
Cellulose-5 column running at 0.5 mL/min of ethanol at ambient
temperature and were detected by a diode array detector (DAD) at 254
nm. The injection volume was 4 μL, and the retention times were 2.4
and 2.9 min for the S and R enantiomers, respectively. The
enantiomeric excess was calculated on the basis of the integrated
peak areas according to E = (AR − AS)/(AR + AS).
3. RESULTS
3.1. Solubility and Phase Diagrams. In order to design a
deracemization process employing R (form I) seeds and racemic
compound crystals, we ﬁrst measured the solubility of the three
crystalline phases of NCPA in acetonitrile containing 1.27 wt %
DBU (Table 1). Under these fast solution racemization
conditions, conglomerate crystals and racemic crystals behave
similarly to polymorphs, and transformations between the
phases are possible.19 It is seen that at 21 °C in acetonitrile, the
order of solubility is form I > racemic compound > form II.
Conglomerate form II, being 13% less soluble than the racemic
compound, is therefore the most stable form at 21 °C.
On the basis of the solubilities of the phases reported in Table
1 and assuming the validity of Meyerhoﬀer’s double-solubility
rule17 for the conglomerates and a solubility product of (CRCS)*
Figure 1. (top) Schematic description of the experimental setup used in
this study and the basic concept for deracemization: gradually fed
metastable racemic compound crystals (red−blue blocks) are
converted in situ to crystals of a single chirality (blue blocks) through
solvent-mediated crystal transformation under racemizing conditions.
(bottom) Racemization reaction of N-(2-chlorobenzylidene)-
phenylglycine amide (NCPA) in the presence of catalytic 1,8-
diazabicyclo[5.4.0]undec-7-ene (DBU).
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= (CRAC* /2)
2 for the racemic compound,17 the phase diagram at
21 °C in acetonitrile is deduced and reported in Figure 2. It is
noted that since the racemization catalyst (DBU) was not found
to signiﬁcantly aﬀect the solubilities, this phase diagram can be
used to describe and interpret transformation behavior both
with and without the racemization catalyst. In the absence of the
racemization catalyst and given enough time, a suspension of
conglomerate form II will equilibrate with the solution, since
form II is the most stable form. Depending on the overall
composition, this suspension contains a mixture of both
enantiopure crystals or only crystals of a single handedness
(light blue shaded region and red shaded regions in Figure 2 top,
respectively). On the other hand, the racemic compound is only
slightly more stable than conglomerate form I. Thus, in the
absence of form II and provided that the crystal transformation
kinetics to form II are slow, there exists a rather narrow
compositional region in which a suspension of only racemic
compound crystals is in a metastable equilibrium with the
solution (dark blue shaded region in Figure 2 top).
In order to study the possibility for deracemization in this
complex system, a series of experiments were designed in which
a mixture of form I crystals of the R enantiomer and crystals of
the racemic compound were slurried together in acetonitrile (21
°C) under grinding conditions in the presence of small amounts
of water. An overview of the conditions of the experiments
performed is presented in Table 2.
Experiments B2−B4 are all started using the same solid
content comprised of 70.6% racemic compound and 29.4% of
the R enantiomer (form I) corresponding to point A in Figure 2
(top). Since the racemization catalyst is not present initially, two
scenarios are envisaged for these experiments on the basis of the
phase diagram in Figure 2. In the ﬁrst scenario, the stable form II
does not form; thus, dissolution occurs until the solution
composition reaches the metastable eutectic point E1 (liquid
phase enantiomeric excess E = 4.1%), leading to enrichment of
the solids in the R enantiomer (63% racemic compound and
37% conglomerate I). In the second scenario, the stable form II
does form and the solution composition shifts toward the stable
eutectic point E2 (E = 0%).
Figure 2 (bottom) shows what happens in the two scenarios
once the racemization catalyst is added 17 min after the start of
these experiments. In the ﬁrst scenario, in the absence of stable
form II, the solution composition at point E1 is enriched with R
and therefore, in the presence of the racemization catalyst,
conversion of the excess R enantiomer to the S enantiomer will
occur (line E1G). At point G, the solution is supersaturated with
respect to the racemic compound, which induces its
crystallization and the concentration in the solution following
line GC. Since at point C the solution is now undersaturated
with respect to form IR crystals, further dissolution of theR form
I crystals occurs, followed again by racemization and
crystallization of the racemic compound until all R form I
crystals convert to the racemic compound.
Adding racemization catalyst during the second scenario
when R crystals of stable form II have formed and the solution
composition is closer to point E2, dissolution of the racemic
compound will occur (line E2C), followed by crystallization of R
form II crystals (line CD) and eventual conversion of S
molecules to R through the racemization to remove the
enrichment of S (diagonal line DF). This in turn causes further
crystallization of the R enantiomer, which is again followed by
racemization and so forth, overall bringing the solution
composition gradually closer to E2. Note that, depending on
the racemization kinetics, the solution composition could
alternatively follow directly dashed line DE2, which corresponds
to the crystallization of the S form II crystals. Near point E2 the
solution is again undersaturated with respect to the racemic
compound; thus, the process repeats until all of the racemic
compound crystals convert to form II crystals.
Thus, in Figure 2, bottom, the line E2CDF represents the
deracemization process, possible through the transformation of
the racemic compound to stable form II and the fast
Table 1. Solubilities of the Solid Phases of NCPA under Fast
Racemization Conditions (1.27 wt % of DBU in Acetonitrile
at 21 °C)
NCPA solid phase solubility (mg/g solvent)
form I CI* 42.5
form II CII* 35.6
racemic compound CRAC* 40.8
Figure 2. Phase diagram of R- and S-NCPA at 21 °C in acetonitrile
without (top) and with racemization (bottom). Lines E2CDF and
E1GC in the bottom ﬁgure represent the deracemization process by
conversion of the racemic compound to conglomerate II and the
undesirable conversion of conglomerate I to the racemic compound,
respectively.
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racemization, while line E1GC represents the undesirable
transformation of metastable form I to the racemic compound.
In order to prevent the latter transformation, care must be taken
to have stable form II crystals present in the system. Therefore,
in starting an experiment with single-enantiomer seeds of the
metastable form I, the racemization catalyst should be added
only later to allow some time for the formation of the stable form
II crystals. It is noted that since stable form II seeds of the
preferred enantiomer were initially unavailable, it was deemed
necessary to start most experiments using single-enantiomer
seeds of the metastable form I.
3.2. Eﬀect of Water. The evolution of the solid-phase
composition for experiments B1−B4, measured by Raman
spectroscopy, are presented in Figure 3. Experiments B2−B4
were conducted under the same conditions, with the only
diﬀerence being the amount of water added in the mixture.
Despite its higher amount of solid and slightly diﬀerent initial
composition, experiment B1 without any added water is
included in this series of experiments B1−B4. For all of these
experiments the racemization catalyst was added only after 17
min.
As seen in Figure 3, regardless of the amount of water,
metastable form I disappears almost completely within∼40 min
for experiments B2−B4. In experiment B1 (Figure 4, top left),
where no water is added, form I also disappears, but in a slower
fashion than in cases B2−B4. Additionally, in B1, form II does
not form at all within the ﬁrst 17min before the catalyst is added,
while after catalyst addition it is only forming very slowly (Figure
2, top left). Addition of the catalyst triggers the racemization of
the excess R-NCPA molecules in the solution and the
subsequent conversion to the racemic compound (line E1GC
in Figure 3 bottom). Finally, in the absence of added water, the
racemic compound is very slowly converting to form II, with the
conversion being negligible even after 48 h (not shown here).
HPLC indicates that no deracemization occurs under these
conditions.
Conversely, in cases where water is added to the mixture
(B2−B4), the formation of form II is accelerated substantially,
Table 2. Overview of the Process Conditions in the Deracemization Experimentsa
expt XRAC (wt %) XI (wt %) total solid mtot (g) water (g) beads (g) DBU (g) solubility of cong II CII* (mg/g solvent) yield y (%) ﬁnal E of R (%)
B1 80.0 20.0 4.00 0.00 10.0 0.2 35.6 75.0 3.0
B2 70.6 29.4 2.72 0.65 10.0 0.2 43.2 60.0 42.0
B3 70.6 29.4 2.72 1.30 10.0 0.2 48.2 81.0 100
B4 70.6 29.4 2.72 2.60 10.0 0.2 48.3 60.0 100
SB1 70.6b 29.4b 6.56b 3.90b 10.0 0.6 48.6 78.3 100
SB2 54.8b 45.2b 6.56b 3.90b 10.0 0.6 48.6 79.7 100
aThe metastable form I seeds were of the R enantiomer. In all experiments, DBU was added 17 min after the start of the experiment and the mass
of acetonitrile added was in all cases 15.72 g (20 mL). bTotal solid and water for the semibatch experiments is after all additions, while the mass
fractions XI and XRAC are the initial ones.
Figure 3. In situ Raman monitoring of the temporal evolution of the solid-phase fractions of NCPA in batch deracemization experiments (B1−B4,
Table 2), starting with mixtures of R form I crystals and racemic compound in acetonitrile/water mixtures at 21 °C in the presence of DBU under
grinding conditions. Red, green, and black points refer to form I (XI), form II (XII), and the racemic compound (XRAC), respectively.
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with the acceleration being highly dependent on the amount of
water present. Thus, when the racemization catalyst is added
after 17 min, the form II fractions are already 5.9%, 27%, and
29.6% for experiments B2−B4, respectively. In particular, for
experiment B4, the metastable form I to stable form II
transformation is almost complete when the catalyst is added;
thus, no crystallization of the racemic compound is observed
with its fraction decreasing monotonically. For experiments B2
and B3, addition of the catalyst leads to some conversion of the
residual form I to the racemic compound (Figure 2, line CE3),
but since a substantial amount of form II has already formed, the
conversion to form II progresses further. Finally, for experiments
B3 and B4, all of the solid phase transforms to the stable form II
within 290 and 140 min, respectively.
In order to obtain further insight into the eﬀect of water, we
measured the solubility of conglomerate form II in various
acetonitrile/water mixtures at 21 °C corresponding to the
conditions of experiments B1−B4. While the solubilities of the
racemic compound and conglomerate form I could not be
measured reliably in the mixed solvent system due to the fast
transformations, it is expected thermodynamically that the
relative solubility diﬀerences will be similar to those in the pure
acetonitrile system, reported in Table 1.42,43 Thus, while the
presence of water would aﬀect the actual values of the phase
diagram reported in Figure 2, the qualitative behavior is
expected to be similar. The solubility results of NCPA
conglomerate form II as a function of water content are
shown in Figure 4.
Although NCPA is hardly soluble in pure water, the NCPA
solubility in acetonitrile increases upon increasing the water
mass fraction to ∼7.5%, after which the solubility reaches a
plateau value of ∼48 mg/g solvent, which pertains up to water
fractions of 20%. Such appearances of maxima in solubility are
not uncommon for organic compounds in mixed organic/
aqueous solvents but have a complex thermodynamic basis
arising from both enthalpy and entropy eﬀects and have not yet
been fully described.44 Nevertheless, the increase in solubility
may partially explain the enhancement in the rate of the crystal
transformations upon water addition, since a higher solubility
leads not only to enhanced mass transfer but also to lower
interfacial tension and thus a lower free energy barrier for the
nucleation of the stable form II.45 Although further research is
needed to elucidate the exact eﬀect of water, the results suggest
that the nucleation and growth kinetics of the stable form II are
substantially increased by the amount of water added. In
addition to an increase in the solubility, a protic solvent such as
water could also lead to degradation of NCPA (e.g., by
hydrolysis of the imine bond). In order to conﬁrm the chemical
stability of NCPA in the presence of water, an additional
experiment was performed (see the Supporting Information), in
which pure NCPA was slurried for 48 h in an acetonitrile−
water−DBU system at room temperature. 1H NMR spectra
conﬁrmed that no such degradation of NCPA occurs under the
experimental conditions relevant to this work.
3.3. Online Estimation of the Enantiomeric Excess
from Raman Data. The in situ Raman data collected for
experiments B1−B4 can be used to monitor the evolution of the
solid-phase enantiomeric excess, provided that the forms present
(either I or II) remain a single enantiomer: i.e., no crystallization
of the counter enantiomer crystals occurs. Then, the Raman-
based enantiomeric excess can be simply calculated as the sum of
the form I and II fractions present at any given time. Figure 5
(left) presents a comparison of the sum of the form I and II
Figure 4. Solubility of NCPA conglomerate form II in various
acetonitrile/water/DBU mixtures at 21 °C. The line is a guide to the
eye.
Figure 5. (left) Evolution of solid-phase enantiomeric excess during deracemization experiments, starting with mixtures of R form I crystals and the
racemic compound in acetonitrile/water mixtures at 21 °C in the presence of DBU under grinding conditions. Filled symbols are enantiomeric excess
estimates from the Raman measurements assuming the absence of counter enantiomer nucleation, while open symbols are the enantiomeric excess
values measured oﬄine by chiral HPLC. See Table 2 for the experimental conditions of experiments B1−B4. (right) Fraction of the total solid present
as counter enantiomer (S) crystals for the same experiments.
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fractions present at any time, as measured by Raman, against the
actual solid-phase enantiomeric excess measured oﬄine by
chiral HPLC. While experiment B1 results in the racemic
compound and unsuccessful deracemization, experiment B4
results in conglomerate crystals and complete deracemization at
the end of the process. Overall, a very good agreement is
obtained between the enantiomeric excess determined from the
sum of the form I and II fractions and that from HPLC,
demonstrating the ability of Raman spectroscopy to monitor in
real time the deracemization process under the experimental
conditions studied here.
However, it is seen that the Raman data consistently slightly
overestimate the actual enantiomeric excess, which indicates
that formation of the counter enantiomer may take place to
some small extent. The combination of the form I and II
fractions XI and XII from Raman and the enantiomeric excess E
determined fromHPLC results for the oﬄine samples allows the
calculation of the total fraction of counter enantiomer (S)
present as form I and II crystals during the process according to
the equation
X
X X E
2S ,con
I II= + −
(2)
Figure 5 (right) shows the evolution of the counter enantiomer
form I and II fractions formed during experiments B1−B4. For
experiments B3 and B4 that led to enantiopurity, the amount of
counter enantiomer formed increases initially up to a maximum
(∼6%) around the point when the racemic crystals completely
dissolve (Figure 3), after which it starts to decrease. During the
racemic compound dissolution phase, the concentration of both
enantiomers in the liquid phase remains high, creating
supersaturation with respect to both enantiomers of the less
soluble form II. Since only the R enantiomer is seeded, it
crystallizes more quickly than the S enantiomer, which leads to
the conversion of some supersaturation of the S enantiomer to
supersaturation for the R enantiomer through the racemization.
However, while dissolution of the racemic compound keeps
occurring, the supersaturation for the S enantiomer is
continuously replenished, eventually leading to the formation
of S form II crystals. Once the racemic compound is depleted,
the supersaturation for the S enantiomer cannot be further
sustained, which causes its formation to stop. Eventually, the
small amount of S enantiomer form II formed converts fully to R
enantiomer form II through Viedma ripening.
3.4. Semibatch Experiments. It is clear from the results
presented in the previous sections that complete deracemization
of NCPA is possible in batch experiments. In addition, Raman
spectroscopy oﬀers the ability to monitor in situ the temporal
evolution of the solid-phase fractions in those experiments,
which in this case gives an overall good online estimation of the
enantiomeric excess throughout the process. However, it is seen
that in many cases formation of counter enantiomer
conglomerate crystals of form II can still occur. While these
can still be converted to the preferred enantiomer through
Viedma ripening, the process becomes slower. Thus, for an
eﬃcient deracemization process, it is preferable to suppress the
formation of counter enantiomer crystals. In the batch
experiments, this is possible by operating the process at
relatively high solid loading and relatively high seed/racemic
compound ratio in combination with grinding to ensure that
Figure 6. (top row) In situ Raman monitoring of the temporal evolution of the solid phase fractions of NCPA during semibatch deracemization
experiments (SB1 and SB2, Table 2). (bottom row) Comparison of enantiomeric excess (open points) with Raman form I and II fractions (dots).
Arrows indicate the points of racemic compound addition (1.92 g/addition for SB1 and 0.96 g/addition for SB2).
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crystallization of the seeded enantiomer takes place much faster
than the crystallization of the counter enantiomer. However,
operating under such conditions in batch leads to low
productivity, as the amount of racemic compound to convert
per batch is rather low, while increasing the solids loading
requires the availability of a high amount of enantiopure seeds.
From a production standpoint, it thus seems preferable to
start the process with a given (low) amount of enantiopure seeds
and gradually feed small amounts of racemic compound, in a
semibatch operation, allowing it to convert before a new
addition. In this way, it is ensured that the supersaturation for
the counter enantiomer remains low throughout the entire
process, preventing the formation of counter enantiomer
crystals. In addition, the system is auto seeded since the crystals
of the preferred enantiomer accumulate in the reactor and
provide ample surface area for the preferential crystallization of
that enantiomer during subsequent additions, circumventing the
need for large amounts of enantiopure seeds. Such a semibatch
operation would be analogous to semibatch bioreactors,46 in
which nutrients are intermittently added to prevent inhibitory
actions present at high nutrient concentration or alteration of
the product distribution (e.g., excessive ethanol production at
high glucose concentrations during baker’s yeast production46),
and is a ﬁrst step toward continuous deracemization. Moreover,
semibatch deracemization could beneﬁt substantially from
Raman spectroscopy, as Raman may be used to monitor the
evolution of the process and provide information on appropriate
feeding strategies or even be used in conjunction with feedback
control systems to fully automate the process.
In order to investigate the potential of semibatch deracemiza-
tion, we carried out two additional experiments, SB1 and SB2
(see Table 2), in which the racemic compound was added
gradually in the suspension. In both experiments, the same total
amount of racemic compound (5.76 g in 20 mL of solvent) was
added over a period of a little more than 3 days. In SB1, the
racemic compound was added in three additions of 1.92 g each,
approximately every 22 h, while in SB2, it was added in six
additions of 0.96 g approximately every 11 h, leading to the same
average addition rate of ∼1.4 mg/min of racemic compound. In
both experiments, an amount of water (1.3 and 0.65 g for SB1
and SB2, respectively) was also added together with the racemic
compound, leading to a gradual increase in the water
concentration in the experiments. While water addition helps
in enhancing the rate of crystal transformations, in some of our
earlier experiments (not reported here) that were started at
lower DBU concentration (1.2 wt %), it was found that
racemization stopped above a water concentration of ∼14 wt %.
This eﬀect is most probably related to the deprotonation of
water by DBU, which then becomes a weaker base and thus
exhibits less catalytic activity. It was possible to circumvent this
eﬀect by increasing the concentration of DBU (3.4 wt %), so as
to maintain a pH of around 12, as reported elsewhere.39
The evolution of the solid-phase fractions for experiments
SB1 and SB2, measured by Raman spectroscopy, is reported in
Figure 6 (top row). It is seen that Raman captures well the eﬀect
of racemic compound addition, with the racemate fraction
increasing and the form II fraction decreasing upon every
addition. It can also be seen that after a new addition of the
racemic compound a fast and full transformation occurs to form
II. A similar oscillating trend is observed in the solid-phase
enantiomeric excess (Figure 6, bottom), where a sharp decrease
is obtained right after the addition of the racemic compound,
followed by an increase up to E > 99%, as the racemic compound
gradually converts to R form II crystals after each addition. As
expected, the decrease in the mass fraction of form II, and thus
the enantiomeric excess, is less pronounced after each addition,
as the form II crystals of theR enantiomer build up in the reactor,
leading to an increase in the suspension density.
Figure 6 also shows that the evolution of the enantiomeric
excess during the semibatch process is directly estimated in real
time by the Raman fractions with very good accuracy, possibly
eliminating the need for manual sampling in those experiments.
This in turn indicates that, as expected during the semibatch
experiments, crystallization of the counter enantiomer is unlikely
to occur, as the system remains well-seeded by the preferred
enantiomer throughout the process. Table 2 shows the yields for
the experiments, which are similar and on the order of ∼80% of
the theoretical yield, with losses pertaining most probably due to
sampling and ﬁltration, indicating that the semibatch crystal
transformation process is a feasible approach to obtain
enantiopure solids.
4. DISCUSSION
While the usefulness of PATs in the design and control of
crystallization processes has been demonstrated with consid-
erable success, their use in chiral crystallization and deracemiza-
tion has generally been diﬃcult. By exploiting the ability of
Raman spectroscopy to capture the diﬀerent packings of the
racemic compound and conglomerate crystals, we have
demonstrated that online Raman spectroscopy can be used to
quantify the solid-phase fractions during deracemization
experiments in which various crystal structures (conglomerate
and racemic compound) are involved.
On the basis of the temporal evolution of the solid-phase
fractions enabled by Raman and the derived phase diagram for
the studied NCPA system, it was possible to elucidate the crystal
transformations possible under the various operating conditions
and their inﬂuence on deracemization (Figure 7). In the absence
of racemization, starting from form I crystals of a single
enantiomer, one can obtain form II crystals of the same
enantiomer in an acetonitrile−water system. However, when
racemization is enabled by DBU, form I converts ﬁrst to the
racemic compound in a pure acetonitrile−DBU system or
directly to racemic conglomerate form II in an acetonitrile−
Figure 7. Possible transformation pathways between the various NCPA
crystal structures in acetonitrile in the presence of water and/or
racemization catalyst (DBU).
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water−DBU system. On the other hand, the racemic compound
may directly convert to form II crystals of a single enantiomer or
racemic conglomerate form II in the presence and absence of
racemization, respectively. Finally, it is possible to convert
racemic conglomerate form II crystals to form II crystals of a
single enantiomer by grinding in the presence of racemization
(Viedma ripening). By careful management of the experimental
process parameters (racemization, amount of water) one can
control the crystal transformations involved and achieve
complete deracemization for this complex system.
Importantly, the results reveal that, for many of these
deracemization experiments, knowledge of the evolution of
the solid-phase composition can be used to infer the evolution of
the solid-phase enantiomeric excess with good accuracy.
However, it is noted that prediction of the enantiomeric excess
using Raman data can only be achieved in highly speciﬁc cases,
such as that reported in this work, which combine conglomerate
crystallization, solution racemization, and such polymorphic
behavior. Additionally, since Raman cannot distinguish between
conglomerate crystals of diﬀerent chiralities, the method fails if a
substantial amount of the counter enantiomer conglomerate
crystals is formed. While in those cases additional oﬄine
measurement is still needed to monitor the deracemization
process, the Raman data remain useful, as their combination
with the oﬄine enantiomeric excess measurements can provide
information on the kinetics of the undesired enantiomer
formation. Overall, the results of this work emphasize the
usefulness of in situ Raman spectroscopy in the development of
complex (continuous) chiral crystallization processes involving
various types of crystalline racemates. Although here we focused
on deracemization through a metastable racemic compound to
conglomerate transformation, we believe that in situ Raman
spectroscopy may prove useful in other chiral resolution
methods involving various types of crystalline racemates, such
as preferential crystallization of racemic compound forming
systems at the eutectic point.47
Finally, the promising results obtained from the semibatch
experiments may indicate that a fully continuous process could
be an achievable and possibly advantageous operating mode for
deracemization. For the system studied in this work, such a
process could feature continuous feeding of the racemic
compound crystals and continuous product removal followed
by in-line ﬁltration and mother liquor recycle. Since in theory
such a process can be operated at a steady state where the
deracemization rate is maintained constant at high levels and it
also circumvents nonproductive downtime that is required for
collecting the solids, cleaning the reactor, and preparing a new
batch, the productivity could possibly be higher than the batch
process.
5. CONCLUSION
We achieved complete deracemizat ion of N -(2-
chlorobenzylidene)phenylglycine amide (NCPA), a complex
chiral polymorphic system, by exploiting the solvent-mediated
transformation of a racemic compound to a stable conglomerate.
This process, also involving a metastable conglomerate, was
monitored by Raman spectroscopy, which showed the
usefulness of achiral PAT in this deracemization process. The
phase diagram shows that under racemic conditions in the
presence of the racemizing agent the racemic compound is just
slightly more stable than the metastable conglomerate I. Slight
enrichments in the solution in the absence of the racemizing
agent promote the formation of enantiopure crystals of the
enriched form. It turns out that a small water content has a
substantial eﬀect on how the deracemization process proceeds as
well as the successfulness of the deracemization. The semibatch
experiments with intermittent addition of the racemic
compound to the transforming suspension show that this is a
beneﬁcial operation in comparison to batchwise operation. It is
therefore envisaged that a continuous deracemization process
for this compound may well be achievable.
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